Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy

Clinical trial NCT03876938 · UNKNOWN

Trial details

NCT number: NCT03876938
Sponsor: Mahidol University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Antiemetic for Highly Emetogenic Chemotherapy

Start date: 2019-03-01
Primary completion: 2020-08-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.